Treatment of Suspected Opioid Overdose with Naloxone
For a suspected opioid overdose, immediately activate the emergency response system, provide high-quality CPR (compressions plus ventilation) if the person is unresponsive and not breathing normally, and administer naloxone. 1
Initial Assessment and Response Algorithm
Identify suspected opioid overdose:
- Unresponsiveness
- Respiratory depression (slow, shallow, or absent breathing)
- Pinpoint pupils (miosis) - though this may not always be reliable
- Evidence of opioid use nearby
Immediate actions:
Response based on breathing status:
Naloxone Administration
Route of administration: Intranasal or intramuscular routes are both effective 2, 3
Dosing: Follow package instructions for specific formulation
- Repeat doses may be necessary if no response in 2-3 minutes
- More than 20 studies demonstrate naloxone is safe and effective for treating opioid-induced respiratory depression 1
Continue resuscitation: Do not stop CPR while waiting for naloxone to take effect 1
- Naloxone should not delay components of high-quality CPR 1
Post-Administration Management
After return of spontaneous breathing:
Watch for recurrence of overdose:
Transport to healthcare facility:
Important Considerations and Pitfalls
Safety profile: Naloxone has an excellent safety profile and is unlikely to be harmful if given to a person with respiratory depression who does not have an opioid overdose 1
Common pitfalls to avoid:
- Delaying CPR while waiting for naloxone to take effect
- Failing to activate emergency services immediately
- Assuming a single dose of naloxone will be sufficient, especially with long-acting opioids
- Discharging patients too early after naloxone administration
- Failing to recognize that naloxone's duration of action may be shorter than the opioid's effects 4
Potential adverse effects:
By following this algorithm, first responders and healthcare providers can effectively manage suspected opioid overdoses, potentially saving lives while minimizing risks associated with naloxone administration.